Ion Beam Applications SA IBA (GB:0GZK) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Ion Beam Applications SA (IBA) showcased robust growth in its third quarter of 2024, with a significant increase in equipment order intake reaching EUR 215 million and a strong order book valued at EUR 1.4 billion. The company also highlighted a successful EUR 93 million funding round for its joint venture, PanTera, to advance the production of actinium 225, alongside notable progress in its Proton Therapy and Other Accelerators businesses. With a positive financial outlook and strategic investments, IBA remains confident in its performance for the year.
For further insights into GB:0GZK stock, check out TipRanks’ Stock Analysis page.
